Navigation Links
Patients and their doctors have different perceptions about HIV and its treatment

According to results of a nation-wide study published in the latest issue of SAGE Publications' Journal of the International Association of Physicians in AIDS Care (JIAPAC), HIV positive patients and their doctors have very different views about the disease and how it's treated.

The study uncovered differences of opinion between patients and physicians about the initiation of treatment, the various goals of treatment, and even about whether or not the patient understands the doctors' explanations. These and other gaps in perception were revealed in the JIAPAC peer-reviewed article, "State of HIV Treatment: Results of IAPAC Surveys of HIV-Positive Patients and HIV-Treating Physicians in the United States."

The article explores the research findings about the attitudes of more than 500 HIV-positive patients and HIV-treating physicians regarding satisfaction with current treatment options, treatment side effects, patient-physician relationships, the importance of looking healthy, and other aspects related to HIV treatment.

"While the surveys highlighted many similar views between physicians and patients on issues such as treatment goals and satisfaction with currently available antiretroviral drugs," said José M. Zuniga, IAPAC President/CEO and the author of the JIAPAC article, "it is clear that more candid dialogue is needed to ensure a satisfactory treatment experience for people living with HIV/AIDS."


'"/>

Source:SAGE Publications


Page: 1

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs
3. Emory Eye Center Implants Its First Retinal Chips In Patients With Retinitis Pigmentosa
4. Implanted Devices Detect High-Risk Heart Failure Patients
5. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
6. Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients
7. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
8. Single-donor Islet Transplantation Procedure Shows Promise For Patients With Type 1 Diabetes
9. IMF Launches World’s First DNA Database for Myeloma Patients
10. Patients now surviving once-fatal immune disease
11. Patients to benefit from novel technology revolutionizing high-speed molecular imaging
Post Your Comments:
(Date:3/2/2015)... 2, 2015  Businesses have a new option ... Tharon Rankins Enterprises has announced the launch of ... way for businesses to protect their customers, personal ... Beconux is a biometric transaction processing ... similarly to an ATM machine, the new system ...
(Date:2/24/2015)... Feb. 24, 2015 This report analyzes the worldwide ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Middle East ... estimates and forecasts are provided for the period 2013 through ... markets. Market data and analytics are derived from primary and ...
(Date:2/23/2015)... Feb. 23, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... patent 62114357 for DISTRIBUTED VOICE DIRECTED PAYMENT ... introduces a new groundbreaking payment method. Payment accounts may ... may only be accessed if both the speech (the ...
Breaking Biology News(10 mins):Personal Data Protection Company Launches New Product 2World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3
... ductal adenocarcinoma is an almost uniformly fatal disease regardless ... small percentage of patients develop a form of ductal ... earlier, is less aggressive and has a 50 percent ... differently, despite carrying the same basic genetic mutations as ...
... the University of Rochester Biomedical Engineering Department has invented ... stem cells. When he captures cancer cells, he ... harvests them for later use in tissue engineering, bone ... and improve health. With Nichola Charles, Jared Kanofsky, ...
... year to the UK poultry industry but scientists are now ... ?one that can be delivered while they are still in ... provides immunity to IBV has been developed by scientists at ... UK. It can be delivered to chicks still in the ...
Cached Biology News:Genetic pathways to curable and incurable forms of pancreatic cancer identified 2Genetic pathways to curable and incurable forms of pancreatic cancer identified 3Cancer-killing invention also harvests stem cells 2Cancer-killing invention also harvests stem cells 3Cancer-killing invention also harvests stem cells 4In-shell vaccine for chick disease 2
(Date:3/3/2015)... The winners of awards for supply ... the Global Supply Chain Resiliency Council (GSCRC) ... Wednesday, February 25th, 2015, at the Hyatt Regency in ... bring together supply chain risk management and resiliency practitioners ... discipline through opportunities to collaborate, develop and share best ...
(Date:3/3/2015)... March 3, 2015  Thingee Corporation, a software development ... a presentation entitled, "Technology Adoption: Making Reps, Lives Easier" ... Innovations and Technology ,  in Deerfield Beach, ... 13, 2015. Audiences looking to learn how technology can ... to be in the audience for the Thingee presentation. ...
(Date:3/3/2015)... Kindred Biosciences, Inc. (NASDAQ: KIN ), ... of pets, announced today that it will release its fourth ... after the market close. The Company will host a conference ... Interested parties may access the call by dialing toll-free ... using conference ID 98449349.  The call will ...
(Date:3/3/2015)... Mass. (PRWEB) March 03, 2015 Cambridge ... by Semantic Web technology, today announced that it has ... Companies That Matter in Knowledge Management.’ , To ... group of colleagues, analysts and system integrators who identify ... delivery of the right information to the right people ...
Breaking Biology Technology:Global Supply Chain Resiliency Council Names Award Winners 2Global Supply Chain Resiliency Council Names Award Winners 3Global Supply Chain Resiliency Council Names Award Winners 4Thingee to present at 11th Annual Synergistix Users Conference 2Cambridge Semantics Named to KMWorld’s 2015 ‘100 Companies That Matter in Knowledge Management’ 2
... SHANGHAI, July 10 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc.,(Nasdaq: ... in the research, development, manufacture, marketing and,distribution of probiotics ... at 10:00 a.m. EDT on Wednesday, July 15, 2009, ... and full year ended March,31, 2009. , ...
... Corporation (NYSE: SGP ) today announced ... Japan, has received marketing approval for REMERON(R) /Reflex(R) ... depressive disorder.(1) The product was developed jointly with ... Seika will market the product under the trade ...
... MADRID, July 9 , ... take part in an online,seminar entitled "Business Opportunities in the Biotechnology, ... for,foreign companies in the sector in Spain. Experts will respond to ... seminar will be held on the 14th of July (12:00pm - ...
Cached Biology Technology:China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Financial Results 2REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients 2REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients 3REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients 4REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients 5Business Opportunities in Spain's Fast-Growing Biotechnology Industry 2
Anti-Flavocytochrome b Monoclonal, FITC Labeled Research Focus: other Storage: 4C Shipping Temperature: 4C...
Goat polyclonal to CHMP5 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-NKDGVLVDEFGLPQ, corresponding to C terminal amino acids 202-215 of Human CHMP5 Entrez GeneID: ...
... Rabbit polyclonal to MKK6 (phospho S207) ... applications). Antigen: ... around the phosphorylation site of Serine ... Entrez Gene ID: 5608 ...
Rabbit polyclonal to Reptin/TIP49B/RUVB2 ( Abpromise for all tested applications). Antigen: Synthetic peptide (Human) Entrez Gene ID: 10856 Swiss Protein ID: Q6FIB9...
Biology Products: